Key recommendations for primary care from the 2026 GOLD update
Abstract
The Global Initiative for Obstructive Lung Disease (GOLD) has produced yearly recommendations for the diagnosis and management of patients with COPD since 2001. Here, we summarize the key recommendations of the GOLD 2026 document for a primary care audience, highlighting what has changed and what has not since the last document in 2025. Specifically, this document discusses changes (if any) in the following domains: (1) definition of COPD; (2) burden of disease; (3) causes and risk factors; (4) clinical presentation; (5) diagnosis; (6) initial assessment and follow-up, including the new concepts of disease activity, stability and clinical control; (7) prevention, with particular emphasis on vaccinations; (8) pharmacological and non-pharmacological treatment; (9) exacerbation; (10) Multimorbidity and its syndemic origins; and, finally (11) artificial intelligence and emerging technologies in COPD.
// Source
Authors: Àlvar Agustí, Marc Vila, Antoni Sisó‐Almirall, Miguel Román-Rodríguez, Claus Vogelmeier
Institutions: Instituto de Salud Carlos III, Hospital Clínic de Barcelona, Universitat de Vic - Universitat Central de Catalunya, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Universitat de Barcelona, German Center for Lung Research, Consorci d’Atenció Primària de Salut Barcelona Esquerra, Fundació Clínic per a la Recerca Biomèdica, Universitat de les Illes Balears